Related Experiment Videos

Antibiotic uptake by alveolar macrophages of smokers

Insights

Smoking impairs alveolar macrophage antibiotic uptake, especially for certain drugs. Smokers

Area of Science:

  • Pharmacology
  • Immunology

Background:

  • Cigarette smoking, especially with chronic pulmonary disease, elevates respiratory tract infection risk.
  • Certain macrophage functions are adversely affected by smoking-associated pulmonary abnormalities.

Purpose of the Study:

  • To determine the effect of smoking on antibiotic uptake by alveolar macrophages (AM).
  • To investigate how smoking-induced alterations in AM affect drug accumulation.

Main Methods:

  • Alveolar macrophages (AM) were obtained from smokers and non-smokers via bronchoalveolar lavage.
  • Uptake of radiolabeled antibiotics was measured using velocity-gradient centrifugation.
  • Uptake was quantified as the cellular to extracellular antibiotic concentration ratio (C/E).

Main Results:

  • Poor uptake (C/E ≤ 1) of cefamandole and penicillin G by smokers' AM.
  • Similar cellular and extracellular concentrations (C/E ≈ 1) for isoniazid, gentamicin, and tetracycline.
  • Concentrated uptake (C/E = 3–11) of lipid-soluble drugs (lincomycin, chloramphenicol, rifampin) and ethambutol.
  • Massively concentrated uptake (C/E = 23–56) of erythromycin and clindamycin by smokers' AM.
  • Smokers' AM showed greater accumulation of lipid-soluble and actively transported antibiotics compared to non-smokers'.

Conclusions:

  • Smoking significantly alters alveolar macrophage antibiotic accumulation.
  • Augmented uptake of specific antibiotics by smokers' AM may stem from smoking-induced structural and functional changes.

Related Concept Videos